Waverley Pharma Inc. (FRA:5GZ)
Germany flag Germany · Delayed Price · Currency is EUR
0.0120
0.00 (0.00%)
Last updated: Jan 28, 2026, 3:25 PM CET

Waverley Pharma Revenue

Waverley Pharma had revenue of 275.66K CAD in the quarter ending September 30, 2025, with 1,129.68% growth. This brings the company's revenue in the last twelve months to 1.51M, up 2,016.26% year-over-year. In the year 2024, Waverley Pharma had annual revenue of 475.37K with 15.36% growth.

Revenue (ttm)
1.51M CAD
Revenue Growth
+2,016.26%
P/S Ratio
1.09
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.00M EUR

Revenue Chart

* This company reports financials in CAD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024475.37K63.28K15.36%
Dec 31, 2023412.09K-834.74K-66.95%
Dec 31, 20221.25M-506.02K-28.87%
Dec 31, 20211.75M377.74K27.47%
Dec 31, 20201.38M217.83K18.82%
Dec 31, 20191.16M933.87K418.03%
Dec 31, 2018223.40K--
Dec 31, 2017---
Dec 31, 2016---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Manz AG205.12M
Paion AG14.81M
a.i.s. AG12.43M
Medigene AG7.45M
Instant Group AG1.54M
Valora Effekten Handel AG782.05K
elexxion AG301.69K
Arzneiwerk AG VIDA124.96K
Revenue Rankings